AU: Guidance for child-resistant packaging for medicines

05 June 2018

Australia has published a guidance to assists businesses to meet the Australian requirements for child-resistant packaging. The requirements are outlined in Therapeutic Goods Order No. 95 - Child-resistant packaging requirements for medicines 2017 (TGO 95). These requirements apply to prescription, over-the-counter (OTC) and listed medicines. The purpose of TGO 95 is to set particular requirements for the packaging of medicines that present a significant risk of toxicity to children if accidentally ingested. These requirements describe packaging that is designed to be resistant to opening by children, thereby reducing the incidence of accidental poisoning (Australian Government, 8 May 2018).
Click here to read the full guidance for child-resistant packaging in Australia.
Click here for more information about the NVC project Pharmaceutical Packaging Innovation.
Click here for more information about the Live Online NVC E-Course Pharmaceutical Packaging.

This news item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: info@nvc.nl, +31-(0)182-512411.